Targeted high-efficiency, homogeneous myocardial gene transfer.
about
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationGene and cell therapies for the failing heart to prevent sudden arrhythmic deathMyocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeabilityIschemia-reperfusion increases transfection efficiency of intracoronary adenovirus type 5 in pig heart in situ.Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary.Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure modelDevelopment of viral vectors for use in cardiovascular gene therapy.Methods to improve cardiac gene therapy expression.Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines.Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts.Gene therapy approaches to ventricular tachyarrhythmias.The Use of Gene Therapy for Ablation of Atrial Fibrillation.Potential of gene therapy as a treatment for heart failureNew signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy.Gene therapy for ventricular tachyarrhythmias.AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.Biological Therapies for Atrial Fibrillation: Ready for Prime Time?Robust in vivo transduction of a genetically stable Epstein-Barr virus episome to hepatocytes in mice by a hybrid viral vectorPermanent coronary artery occlusion: cardiovascular MR imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine modelVentricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapyGene therapy to treat cardiovascular disease.Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.Site-specific gene therapy for cardiovascular disease.Gene therapy strategies for cardiac electrical dysfunction.Gene delivery methods in cardiac gene therapy.Percutaneous methods of vector delivery in preclinical models.Gene therapy for heart failure: where do we stand?Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.Percutaneous approaches for efficient cardiac gene delivery.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Angiogenic gene therapy for refractory angina.Gene Therapy for Post-infarction Ventricular Tachycardia.Gene Therapy for Cardiac Arrhythmias.Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy.Gene-therapy delivery strategies in cardiology.Phosphorylation of serine96 of histidine-rich calcium-binding protein by the Fam20C kinase functions to prevent cardiac arrhythmia.Recent findings into the potential of gene therapy to reverse heart failure.Rare Diseases: Drug Discovery and Informatics Resource.RP105 alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways.
P2860
Q26799437-B68751A1-AF3E-4D5E-AB59-0998EEF31F04Q26865425-A0E7F874-7580-4EB6-BC45-0AD902C832EAQ30440788-10C9B8BF-78FD-453A-A036-80B64A93E569Q33586284-F86BE091-87E1-4A6B-B9B8-52C0AFAB7233Q34013724-25A3DDD8-41F7-4167-9509-C2C7BE7EB3EBQ34195822-0D588C49-1049-4029-9D1D-48EBCC9BB8DFQ34248473-B75DAC49-D863-48BA-8F5D-C77E76A85612Q35260617-E53769F3-C4D9-4840-96B5-D8D4F7A940AEQ35360600-D1517A93-01EC-49DF-A221-44020E41931AQ35621815-DCF104C2-D204-42A2-8113-1154CCD81B4CQ35802086-F7DE60B0-3F46-4630-968B-CA64631B8F34Q36238863-3DFD195A-FA6C-466F-8BC6-FD6C919F9F4CQ36458906-3D365FF9-6D54-4AFC-893E-AC38E9DC9F44Q36497159-01713D39-C73C-40AE-914F-01D56D7D605FQ36515530-70FA7445-7AB5-4EAC-A866-3DF604321633Q36726175-93E7129C-D366-46F8-9441-AD86E6C3A1F6Q36756838-4B2354BA-8547-4ACF-859E-74C4ACE7A23BQ36934761-506B3F55-DB40-424C-B1A0-BDB329DF47F2Q37127864-0B001D40-1D28-418E-839C-F8290FCE7460Q37133859-44D29B25-D603-4A55-AE18-34D9F08C7D01Q37309270-51583618-A0DB-4E67-B6DD-5C137CEBFC51Q37310450-09D8BC59-94C6-440E-B7ED-EF2917A22984Q37364786-070270ED-0105-49E8-B3CF-15B148F75B14Q37703070-CF15C004-931B-45C7-8744-7AF459AC3ACDQ37778878-9CD95EC5-B7FB-42CA-B99E-0347D560E92AQ37939775-1B3C374E-87AC-4B72-BEF3-F5684496A1A1Q37993680-7EE2C7B3-E49A-44A0-89D2-84E6A0D82114Q38073152-92B0152D-A955-4DEF-B74C-8927FCED85E4Q38081027-F16546DF-A465-4C73-B70B-51C93839A39FQ38113171-8D45555A-D948-4DA7-97F7-0852E4BAAD59Q38132253-397D74EA-DE6B-4D37-868F-A247A5C56F22Q38637597-29137164-41D4-419E-BA52-C3BE6CF7A43DQ39137447-F771A5F8-D7EC-478F-BA94-2108F99F2AD4Q39815208-DE68FBC2-18F0-429B-BF71-340B8388FE45Q39864941-5DF0EA24-BD46-4440-B0AA-3A151ADFEA04Q40119187-D15B3453-A306-4334-9EF8-606913ACC298Q41562221-874E6258-AD30-4B54-965C-5E1CA076A1F0Q45873132-4A994A0A-358E-470D-A6FE-6D76FE13CAB1Q45873887-0D591EEB-5BA5-46D9-8ED9-59C71DA9654AQ52670056-EC13CCC9-D157-4173-AA9F-6B5905D65733
P2860
Targeted high-efficiency, homogeneous myocardial gene transfer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Targeted high-efficiency, homogeneous myocardial gene transfer.
@ast
Targeted high-efficiency, homogeneous myocardial gene transfer.
@en
type
label
Targeted high-efficiency, homogeneous myocardial gene transfer.
@ast
Targeted high-efficiency, homogeneous myocardial gene transfer.
@en
prefLabel
Targeted high-efficiency, homogeneous myocardial gene transfer.
@ast
Targeted high-efficiency, homogeneous myocardial gene transfer.
@en
P2093
P2860
P1476
Targeted high-efficiency, homogeneous myocardial gene transfer.
@en
P2093
Amy D McDonald
J Kevin Donahue
Kan Kikuchi
Shenghan Lai
Tetsuo Sasano
P2860
P304
P356
10.1016/J.YJMCC.2007.02.004
P577
2007-02-14T00:00:00Z